The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I results of GANNET53: A multicenter phase I/II trial of the Hsp90 inhibitor ganetespib (G) combined with weekly paclitaxel (P) in women with high-grade serous, high-grade endometrioid, or undifferentiated, platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer.
 
Nicole Concin
Travel, Accommodations, Expenses - Roche
 
Ioana Braicu
Honoraria - AstraZeneca; Fujirebio Diagnostics; Myriad Genetics; Roche
Consulting or Advisory Role - Glycotope GmbH
Travel, Accommodations, Expenses - Amgen; GlaxoSmithKline
 
Regina Berger
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Sven Mahner
Honoraria - AstraZeneca; GlaxoSmithKline; Janssen-Cilag; Jenapharm; Medac; PharmaMar; Roche/Genentech; Teva
Consulting or Advisory Role - AstraZeneca; Janssen-Cilag; Medac; Merck Sharp & Dohme; Roche; Tesaro
Research Funding - AstraZeneca; Bayer; Boehringer Ingelheim; GlaxoSmithKline; Janssen-Cilag; Medac; PharmaMar; Roche; Tesaro
 
Jalid Sehouli
Honoraria - AstraZeneca; MSD; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; MSD; Roche
Speakers' Bureau - AstraZeneca; PharmaMar; Roche
Research Funding - Amgen (Inst); AstraZeneca (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Alain G Zeimet
No Relationships to Disclose
 
Eric Pujade-Lauraine
Consulting or Advisory Role - AstraZeneca; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche/Genentech
 
Philippe Alexandre Cassier
Honoraria - Blueprint Medicines; Novartis; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bayer (Inst); Blueprint Medicines (Inst); Celgene (Inst); Lilly (Inst); Novartis (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Amgen; Novartis; Roche
 
Ute Martha Moll
No Relationships to Disclose
 
Hanno Ulmer
No Relationships to Disclose
 
Karin Leunen
No Relationships to Disclose
 
Christian Marth
No Relationships to Disclose
 
Ignace Vergote
Consulting or Advisory Role - AstraZeneca (Inst)
 
Isabelle Laure Ray-Coquard
Consulting or Advisory Role - MSD; PharmaMar; Roche
Travel, Accommodations, Expenses - PharmaMar; Roche/Genentech